NMR Instruments
Search documents
Bruker(BRKR) - 2025 Q3 - Earnings Call Presentation
2025-11-03 13:30
Q3 2025 Performance - Revenue decreased by $3.9 million, a -0.5% decline, with organic revenue declining by -4.5%[7] - Non-GAAP EPS decreased by -25% to $0.45[7] - Non-GAAP operating margin decreased by -260 bps to 12.3%[7] Q3 2025 YTD Performance - Revenue increased by $72.5 million, a 3.0% increase, driven by M&A, while organic revenue declined by -3.1%[9] - Non-GAAP EPS decreased by -25.5% to $1.23, including a -$0.09 FX headwind[9, 43] - Non-GAAP operating margin decreased by -290 bps to 11.4%[9] FY 2025 Outlook - Revenue is projected to be between $3.41 billion and $3.44 billion, representing a growth of +1% to +2%[49] - Organic revenue is expected to decline by -4% to -5%, with M&A contributing approximately +3.5%[49] - Non-GAAP EPS is projected to be between $1.85 and $1.90, a decline of -21% to -23%[49]